The Ensign Group (ENSG) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
9 Aug, 2026Executive summary
Achieved record quarterly results with consolidated revenue up 17.3% to $1.44 billion, driven by clinical excellence, local leadership, occupancy growth, and robust acquisition activity, including 20–25 new operations and expansion in Texas and Iowa.
GAAP diluted EPS was $1.68 (up 16.7% YoY); adjusted EPS was $1.92 (up 20.8% YoY); GAAP net income was $99.7 million (up 18.2% YoY); adjusted net income was $114.3 million (up 22.5% YoY).
Over 80% of skilled nursing operations earned a CMS Quality Measure rating of four or five stars, with significant improvements in occupancy, skilled mix, and managed care revenue.
Standard Bearer REIT added $374.6 million in real estate assets and generated $44.1 million in rental revenue, supporting future growth.
Clinical quality, leadership stability, and a mission-focused culture drive sustainable growth and competitive advantage.
Financial highlights
Consolidated GAAP and adjusted revenues reached $1.44 billion for Q2 2026, a 17.3% increase year-over-year; year-to-date revenue was $2.83 billion, up 18%.
Adjusted EBITDA for Q2 2026 was $181.1 million, up from $146.6 million in Q2 2025; adjusted EBITDAR was $247.6 million.
Cash and cash equivalents stood at $262.3 million; cash flows from operations were $272.1 million for H1 2026.
Lease-adjusted net debt to EBITDA/EBITDAR ratio was about 2x, reflecting disciplined leverage.
Gross margin improved as cost of services as a percentage of revenue decreased by 0.6% to 78.9%.
Outlook and guidance
2026 annual earnings guidance raised to $7.75–$7.85 per diluted share, midpoint up 18.7% over 2025 and 41.8% over 2024.
2026 annual revenue guidance increased to $5.87–$5.92 billion.
Guidance incorporates expected acquisitions, operational momentum, normalized insurance costs, and a 25% tax rate.
Management expects continued growth from recent acquisitions and organic improvements in occupancy and acuity.
Ongoing investment in facility renovations and system implementations is planned, with $175 million budgeted for 2026.
Latest events from The Ensign Group
- Q1 2026 revenue up 18.4%, net income up 24.2%, with raised guidance and strong expansion.ENSG
Q1 2026 - Director elections, auditor ratification, and say-on-pay up for vote at annual meeting.ENSG
Proxy filing - 2025 saw record growth, enhanced governance, and performance-driven executive compensation.ENSG
Proxy filing - Strong growth, robust acquisitions, and proactive regulatory management drive future upside.ENSG
Oppenheimer 36th Annual Healthcare MedTech & Services Conference - Record revenue, earnings, and occupancy drive double-digit FY26 growth outlook.ENSG
Q4 2025 - Growth is fueled by leadership, local empowerment, and disciplined acquisitions amid a stable regulatory outlook.ENSG
Stephens 26th Annual Investment Conference | NASH2024 - Q3 revenue up 15%, net income up 22.8%, and guidance raised amid record occupancy and expansion.ENSG
Q3 2024 - Record Q2 growth, raised 2024 guidance, and continued disciplined expansion.ENSG
Q2 2024 - Record 2024 results and strong 2025 outlook driven by growth, acquisitions, and financial strength.ENSG
Q4 2024